Needham reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $9.00 from $14.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/22/2023 | $0.80 → $3.00 | Neutral → Buy | Citigroup |
| 11/26/2021 | $14.00 → $9.00 | Buy | Needham |
BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million[1]), compared with RMB385.3 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB20.3 million (US$2.9 million), compared with net income attributable to So-Young Intern
BEIJING, Nov. 6, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2024, before U.S. markets open on November 20, 2024. So-Young's management will hold an earnings conference call on Wednesday, November 20, 2024, at 7:00 AM U.S. Eastern Time (8:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1
BEIJING, Aug. 23, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenues were RMB407.4 million (US$56.1 million[1]), compared with RMB412.1 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB18.9 million (US$2.6 million), compared with net loss attributable to So-Young Internation
BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million[1]), compared with RMB385.3 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB20.3 million (US$2.9 million), compared with net income attributable to So-Young Intern
BEIJING, Nov. 6, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2024, before U.S. markets open on November 20, 2024. So-Young's management will hold an earnings conference call on Wednesday, November 20, 2024, at 7:00 AM U.S. Eastern Time (8:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1
BEIJING, Aug. 29, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced it has received a notification letter dated August 28, 2024 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Notice
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G - So-Young International Inc. (0001758530) (Subject)
SC 13D - So-Young International Inc. (0001758530) (Subject)
BEIJING, Oct. 12, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that Mr. Min Yu, Mr. Xuejian Li, Mr. Charles Zhaoxuan Yang and Mr. Harry Jiannan Wang have tendered their resignations as directors of the Company for personal reasons, effective as of October 12, 2023. The board of directors of the Company (the "Board") has approved the appointment of Ms. Nan Shen as an independent director of the Company where she will serve as the chair of the audit committee and as a member of the compensat
Citigroup upgraded So-Young International from Neutral to Buy and set a new price target of $3.00 from $0.80 previously
Needham reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $9.00 from $14.00 previously
Canaccord Genuity reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $14.00 from $16.00 previously
SCHEDULE 13G - So-Young International Inc. (0001758530) (Subject)
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)